Asciminib and ponatinib combination in Philadelphia chromosome-positive acute lymphoblastic leukemia
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:62 |
|---|---|
| Enthalten in: |
Leukemia & lymphoma - 62(2021), 14 vom: 02. Dez., Seite 3558-3560 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zerbit, Jérémie [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
25X51I8RD4 |
|---|
| Anmerkungen: |
Date Completed 14.04.2022 Date Revised 14.04.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1080/10428194.2021.1966787 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM329493450 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM329493450 | ||
| 003 | DE-627 | ||
| 005 | 20231225205234.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/10428194.2021.1966787 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1098.xml |
| 035 | |a (DE-627)NLM329493450 | ||
| 035 | |a (NLM)34405773 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zerbit, Jérémie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Asciminib and ponatinib combination in Philadelphia chromosome-positive acute lymphoblastic leukemia |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.04.2022 | ||
| 500 | |a Date Revised 14.04.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Imidazoles |2 NLM | |
| 650 | 7 | |a Protein Kinase Inhibitors |2 NLM | |
| 650 | 7 | |a Pyrazoles |2 NLM | |
| 650 | 7 | |a Pyridazines |2 NLM | |
| 650 | 7 | |a asciminib |2 NLM | |
| 650 | 7 | |a Niacinamide |2 NLM | |
| 650 | 7 | |a 25X51I8RD4 |2 NLM | |
| 650 | 7 | |a ponatinib |2 NLM | |
| 650 | 7 | |a 4340891KFS |2 NLM | |
| 650 | 7 | |a Fusion Proteins, bcr-abl |2 NLM | |
| 650 | 7 | |a EC 2.7.10.2 |2 NLM | |
| 700 | 1 | |a Tamburini, Jerome |e verfasserin |4 aut | |
| 700 | 1 | |a Goldwirt, Lauriane |e verfasserin |4 aut | |
| 700 | 1 | |a Decroocq, Justine |e verfasserin |4 aut | |
| 700 | 1 | |a Cayuela, Jean Michel |e verfasserin |4 aut | |
| 700 | 1 | |a Chapuis, Nicolas |e verfasserin |4 aut | |
| 700 | 1 | |a Contejean, Adrien |e verfasserin |4 aut | |
| 700 | 1 | |a Batista, Rui |e verfasserin |4 aut | |
| 700 | 1 | |a Bouscary, Didier |e verfasserin |4 aut | |
| 700 | 1 | |a Willems, Lise |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Leukemia & lymphoma |d 1989 |g 62(2021), 14 vom: 02. Dez., Seite 3558-3560 |w (DE-627)NLM012624047 |x 1029-2403 |7 nnns |
| 773 | 1 | 8 | |g volume:62 |g year:2021 |g number:14 |g day:02 |g month:12 |g pages:3558-3560 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1080/10428194.2021.1966787 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 62 |j 2021 |e 14 |b 02 |c 12 |h 3558-3560 | ||